Results 151 to 160 of about 32,786 (220)

Oral Presentation

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Atrial function and geometry differences in transthyretin versus immunoglobulin light chain amyloidosis: a cardiac magnetic resonance study. [PDF]

Sci Rep, 2022
Palmer C, Truong VT, Slivnick JA, Wolking S, Coleman P, Mazur W, Zareba KM.   +6 more
europepmc   +1 more source

ePosters Virtual

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Clinical characteristics and prognosis of immunoglobulin light chain amyloidosis patients. [PDF]

Front Med (Lausanne)
Song L, Su Y, Li R, Du S, Xue Y, Gu Y, Chen J, Xing X, Shen Z, Wei Y.   +9 more
europepmc   +1 more source

Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry.

Blood, 2017
T. Kourelis, S. Dasari, J. Theis, M. Ramirez-Alvarado, Paul J. Kurtin, M. Gertz, S. Zeldenrust, Roman M. Ženka, A. Dogan, A. Dispenzieri   +9 more
semanticscholar   +1 more source

Proving Bone Marrow Plasma Cell Clonality by Flow Cytometry: An Important Tool in the Diagnosis of Immunoglobulin Light-Chain Amyloidosis. [PDF]

Biomedicines
Badelita SN, Sandu HM, Coriu D, Jercan A, Barbu S, Zidaru L, Himcinschi ME, Dobrea C, Popescu M, Popa DC.   +9 more
europepmc   +1 more source

Evaluation of Cytokine Levels in Cardiac Transthyretin and Immunoglobulin Light Chain Amyloidosis and Their Correlation with Myocardial Inflammatory Cells and MACE. [PDF]

Biomedicines
Musigk N, Suwalski P, Müller M, Violano M, Klingel K, Weiner J, Beule D, Landmesser U, Heidecker B.   +8 more
europepmc   +1 more source

Periorbital Purpura as a Key Diagnostic Clue in Immunoglobulin Light Chain Amyloidosis. [PDF]

JMA J
Miyaue K, Isono H.
europepmc   +1 more source

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14-Year Experience of an Academic Center. [PDF]

Hematol Oncol
Dima D, Goel U, Ullah F, Faiman B, Basali D, Mazzoni S, Williams LS, Samaras C, Valent J, Anwer F, Khouri J, Raza S.   +11 more
europepmc   +1 more source

Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre Experience. [PDF]

Cancers (Basel)
Alejo E, Agulló C, Puertas B, Eiros R, Rey-Búa B, Barnés C, Rodríguez-González M, López-Corral L, Santos-Briz Á, Escalante F, Pérez-García ML, Jiménez-Cabrera S, Gutiérrez NC, Puig N, Mateos MV, González-Calle V.   +15 more
europepmc   +1 more source